BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3000429)

  • 1. Ca2+-dependent cyclic nucleotide phosphodiesterase is activated by poly(L-aspartic acid).
    Tanaka T; Ito M; Ohmura T; Hidaka H
    Biochemistry; 1985 Sep; 24(19):5281-4. PubMed ID: 3000429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium-independent activation of calcium ion dependent cyclic nucleotide phosphodiesterase by synthetic compounds: quinazolinesulfonamide derivatives.
    Tanaka T; Yamada E; Sone T; Hidaka H
    Biochemistry; 1983 Mar; 22(5):1030-4. PubMed ID: 6301535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of the dihydropyridine calcium antagonist, CD-349, with calmodulin.
    Tanaka M; Muramatsu M; Aihara H; Otomo S
    Biochem Pharmacol; 1990 Sep; 40(5):991-6. PubMed ID: 2167684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct interaction of calmodulin antagonists with Ca2+/calmodulin-dependent cyclic nucleotide phosphodiesterase.
    Itoh H; Hidaka H
    J Biochem; 1984 Dec; 96(6):1721-6. PubMed ID: 6099352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of calmodulin function by CV-159, a novel dihydropyridine compound.
    Umekawa H; Yamakawa K; Nunoki K; Taira N; Tanaka T; Hidaka H
    Biochem Pharmacol; 1988 Sep; 37(18):3377-81. PubMed ID: 2844186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclic nucleotide phosphodiesterase of rat pancreatic islets. Effects of Ca2+, calmodulin and trifluoperazine.
    Sugden MC; Ashcroft SJ
    Biochem J; 1981 Aug; 197(2):459-64. PubMed ID: 6275834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ca2+-calmodulin-activated cyclic nucleotide phosphodiesterase from the rabbit myometrium].
    Osipenko AA; Prishchepa LA; Kurskiĭ MD
    Ukr Biokhim Zh (1978); 1986; 58(4):26-31. PubMed ID: 3016961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of ruthenium red on activation of Ca2(+)-dependent cyclic nucleotide phosphodiesterase.
    Masuoka H; Ito M; Nakano T; Naka M; Tanaka T
    Biochem Biophys Res Commun; 1990 May; 169(1):315-22. PubMed ID: 1693502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrophobic interaction of the Ca2+-calmodulin complex with calmodulin antagonists. Naphthalenesulfonamide derivatives.
    Tanaka T; Ohmura T; Hidaka H
    Mol Pharmacol; 1982 Sep; 22(2):403-7. PubMed ID: 7144734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new peptide (1150Da) selectively activates the calcium-calmodulin sensitive isoform of cyclic nucleotide phosphodiesterase from human myometrium.
    Leroy MJ; Dumler I; Lugnier C; Shushakova ND; Ferré F
    Biochem Biophys Res Commun; 1992 Apr; 184(2):700-5. PubMed ID: 1315529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of K-252a, a potent microbial inhibitor of protein kinase, on activated cyclic nucleotide phosphodiesterase.
    Matsuda Y; Nakanishi S; Nagasawa K; Iwahashi K; Kase H
    Biochem J; 1988 Nov; 256(1):75-80. PubMed ID: 2851986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of calmodulin function and of Ca2+-induced smooth muscle contraction by the calmodulin antagonist, HT-74.
    Tanaka T; Umekawa H; Saitoh M; Ishikawa T; Shin T; Ito M; Itoh H; Kawamatsu Y; Sugihara H; Hidaka H
    Mol Pharmacol; 1986 Mar; 29(3):264-9. PubMed ID: 3005834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation of an enzymatically active cross-linked complex between brain cyclic nucleotide phosphodiesterase and 3-(2-pyridyldithio)propionyl-substituted calmodulin.
    Kincaid RL
    Biochemistry; 1984 Mar; 23(6):1143-7. PubMed ID: 6324862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteolytic activation of calmodulin-dependent cyclic nucleotide phosphodiesterase.
    Kincaid RL; Stith-Coleman IE; Vaughan M
    J Biol Chem; 1985 Jul; 260(15):9009-15. PubMed ID: 2991233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Ca2+ -activated protease (calpain) modulates Ca2+/calmodulin dependent activity of smooth muscle myosin light chain kinase.
    Ito M; Tanaka T; Nunoki K; Hidaka H; Suzuki K
    Biochem Biophys Res Commun; 1987 Jun; 145(3):1321-8. PubMed ID: 3038096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A model for the regulation of the calmodulin-dependent enzymes erythrocyte Ca2+-transport ATPase and brain phosphodiesterase by activators and inhibitors.
    Gietzen K; Sadorf I; Bader H
    Biochem J; 1982 Dec; 207(3):541-8. PubMed ID: 6299272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and characterization of bovine lung calmodulin-dependent cyclic nucleotide phosphodiesterase. An enzyme containing calmodulin as a subunit.
    Sharma RK; Wang JH
    J Biol Chem; 1986 Oct; 261(30):14160-6. PubMed ID: 3021730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and characterization of a Ca2+-calmodulin-sensitive cyclic nucleotide phosphodiesterase in a human lymphoblastoid cell line.
    Epstein PM; Moraski S; Hachisu R
    Biochem J; 1987 Apr; 243(2):533-9. PubMed ID: 2820385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two types of calmodulin antagonists: a structurally related interaction.
    Inagaki M; Hidaka H
    Pharmacology; 1984; 29(2):75-84. PubMed ID: 6089236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of human platelet secretion and of Ca2+, calmodulin-dependent protein phosphorylation by the antiallergic agent GMCHA.
    Tanaka T; Saitoh M; Ito M; Shin T; Naka M; Endo K; Hidaka H
    Biochem Pharmacol; 1988 Jul; 37(13):2537-42. PubMed ID: 3390216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.